Cargando…
Transcriptomic Characterization of Hepatocellular Carcinoma with CTNNB1 Mutation
PURPOSE: Hepatocellular carcinoma (HCC) is the sixth most common solid tumor worldwide and the third leading cause of cancer-related death. HCC is a particularly serious threat to the Chinese population. Although many molecular alterations are known to be involved in the tumorigenesis of hepatocytes...
Autores principales: | Ding, Xiao, Yang, Yuan, Han, Baoda, Du, Chengzhi, Xu, Naiqing, Huang, Huanwei, Cai, Tao, Zhang, Aiqun, Han, Ze-Guang, Zhou, Weiping, Chen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010419/ https://www.ncbi.nlm.nih.gov/pubmed/24798046 http://dx.doi.org/10.1371/journal.pone.0095307 |
Ejemplares similares
-
Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2016) -
An Integrative Analysis Reveals the Underlying Association Between CTNNB1 Mutation and Immunotherapy in Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2020) -
Prognostic significance of CTNNB1 mutation in hepatocellular carcinoma: a systematic review and meta-analysis
por: Lu, Genlin, et al.
Publicado: (2023) -
Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients
por: Lin, Selena Y., et al.
Publicado: (2021) -
Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
por: He, Juan, et al.
Publicado: (2021)